NASDAQ:TNXP

Tonix Pharmaceuticals Stock Insider Trading

$32.36

-1.96 (-5.71%)

At Close: Jun 20, 2025

Tonix Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 98.60. In total, the insiders bought 48 482 305 and sold 9 402 TNXP shares in the last 100 trades.

Insider Power (Last 100 transactions)	98.60
Buy	48 482 305 Shares
Sell	9 Shares

Historical Insider Trades

Date	Type	Action	Person	Amount
Jun 12, 2025	Stock Option	Buy	Hunter James Randolph Jr	7 740
Jun 12, 2025	Stock Option	Buy	Hunter James Randolph Jr	7 740
May 15, 2025	Common Stock, $0.001 par value	Buy	Lederman Seth	4 000
May 13, 2025	Stock Option	Buy	Treco James	10 000
May 13, 2025	Stock Option	Buy	Bell Margaret Smith	10 000
May 13, 2025	Stock Option	Buy	Taylor Carolyn E.	10 000
May 13, 2025	Stock Option	Buy	Bagger Richard H	10 000
May 13, 2025	Stock Option	Buy	Stillwell Richard Newcomb	10 000
May 13, 2025	Stock Option	Buy	Olukotun Adeoye Y	10 000
May 13, 2025	Stock Option	Buy	Grange David L	10 000
Feb 27, 2025	Stock Option	Buy	Fogarty Siobhan	26
Feb 25, 2025	Stock Option	Buy	Saenger Bradley	25 792
Feb 25, 2025	Stock Option	Buy	Saenger Bradley	25 792
Feb 25, 2025	Stock Option	Buy	Sullivan Gregory M	29 017
Feb 25, 2025	Stock Option	Buy	Sullivan Gregory M	29 017
Feb 25, 2025	Stock Option	Buy	Lederman Seth	123 958
Feb 25, 2025	Stock Option	Buy	Lederman Seth	123 958
Feb 25, 2025	Stock Option	Buy	Morris Jessica Edgar	29 291
Feb 25, 2025	Stock Option	Buy	Morris Jessica Edgar	29 291
Feb 25, 2025	Stock Option	Buy	Fogarty Siobhan	13 500
Feb 25, 2025	Stock Option	Buy	Fogarty Siobhan	13 500
Feb 05, 2025	Common Stock, par value $0.001	Sell	Bell Margaret Smith	1
Feb 05, 2025	Common Stock, par value $0.001	Sell	Treco James	0
Feb 05, 2025	Common Stock, par value $0.001	Sell	Bagger Richard H	0
Feb 05, 2025	Common Stock, par value $0.001	Sell	Saenger Bradley	0

ABOUT TONIX PHARMACEUTICALS HOLDING CORP.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, auto...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
G GTM $9.57	2.40%	Jun 02
TAC $8.90	23.37%	May 12
IMMR $7.28	4.81%	May 09
UAA $5.84	20.38%	May 09
MEDP $300.81	2.84%	May 08

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by